Bay Area tech companies are battling to build popular, useful artificial intelligence — and the fight just ripped apart a startup. Windsurf, an AI company based in Mountain View, began last week as a reported $3 billion acquisition target for OpenAI.

Cognition CEO Scott Wu and interim Windsurf CEO Jeff Wang said they would start by integrating the AI-powered engineer Devin into Windsurf

Cognition said the deal structure eliminates existing vesting cliffs and provides accelerated vesting for current staff members, recognizing their contributions to building Windsurf's business foundation.

Microcap Cognition Therapeutics (NASDAQ:CGTX) has skyrocketed 35% in Thursday trading after stating the company had a positive end-of-phase 2 meeting with the U.S. FDA for the oral Alzheimer's asset zervimesine and sees a path forward for a phase 3 program.

Goldman Sachs just hired its first AI coder: Goldman is the first major bank to try out Cognition's agentic AI coder, Devin, signaling a seismic shift in how finance works alongside software https://t.co/5CEvbmAPWX pic.twitter.com/Yngj54XCyF — Quartz (@qz) July 11, 2025

Cognition Therapeutics Inc. (NASDAQ:CGTX) saw its stock climb sharply by 75% following a productive end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) concerning its Alzheimer’s drug candidate.

Cognition Therapeutics, Inc. (NASDAQ:CGTX) is among the fundamentally strong penny stocks to invest in. H.C. Wainwright has maintained a $3.00 price target for Cognition Therapeutics, Inc.